PHASE I STUDY OF BMS188667 IN PSORIASIS VULGARIS
PHASE I STUDY OF BMS188667 IN PSORIASIS VULGARIS
批准号:
6244451
负责人:
CYNTHIA GUZZO
金额:
$2.36万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-03-17 至 1998-02-28
关键词:
CD28 molecule T lymphocyte antiallergic agents clinical research clinical trial phase I dosage drug screening /evaluation human subject human therapy evaluation immunopathology immunopathology chemotherapy leukocyte activation /transformation outcomes research pharmacokinetics psoriasis skin disorder chemotherapy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This was a multi-center, open-label dose escalation Phase I trial designed
to test the safety, pharmacokinetics and preliminary biologic activity of
BMS-188667 (CTLA4Ig) administered as four intravenous injections on days
1, 3, 16, and 29 to patients with psoriasis vulgaris. The major goals of
this study were the determination of: the safety, pharmacokinetics,
immunogenicity, recovery time from biological effect and optimal diologic
dose for psoriasis treatment of BMS-188667.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SAFETY, TOLERABILITY, AND BIOLOGIC ACTIVITY OF L 733,723 IN PSORIATIC PATIENTS
-
批准号:6274493
-
项目类别:
-
资助金额:$2.5万
-
财政年份:1998
-
负责人:CYNTHIA GUZZO
-
依托单位:
TOLERABILITY/PHARMACOKINETICS OF DAB389 IL 2 IN PATIENTS WITH SEVERE PSORIASIS
-
批准号:6274518
-
项目类别:
-
资助金额:$2.5万
-
财政年份:1998
-
负责人:CYNTHIA GUZZO
-
依托单位:
BMS 188667 (CTLA4KG) IN PATIENTS WITH PSORIASIS VULGARIS
-
批准号:6274552
-
项目类别:
-
资助金额:$2.5万
-
财政年份:1998
-
负责人:CYNTHIA GUZZO
-
依托单位:
PHASE I STUDY OF BMS188667 IN PSORIASIS VULGARIS
-
批准号:6274478
-
项目类别:
-
资助金额:$2.5万
-
财政年份:1998
-
负责人:CYNTHIA GUZZO
-
依托单位:
DOSE ESCALATION STUDY OF MEDI 507, HUMANIZED MONOCLONAL ANTIBODY CD2
-
批准号:6263605
-
项目类别:
-
资助金额:$2.51万
-
财政年份:1998
-
负责人:CYNTHIA GUZZO
-
依托单位:
TOLERABILITY/PHARMACOKINETICS OF DAB389 IL 2 IN PATIENTS WITH SEVER PSORIASIS
-
批准号:6244504
-
项目类别:
-
资助金额:$2.36万
-
财政年份:1997
-
负责人:CYNTHIA GUZZO
-
依托单位:
SAFETY, TOLERABILITY, AND BIOLOGIC ACTIVITY OF L 733,723 IN PSORIATIC PATIENTS
-
批准号:6244475
-
项目类别:
-
资助金额:$2.36万
-
财政年份:1997
-
负责人:CYNTHIA GUZZO
-
依托单位:
TOLERABILITY/PHARMACOKINETICS OF DAB389 IL 2 IN PATIENTS WITH SEVERE PSORIASIS
-
批准号:6113284
-
项目类别:
-
资助金额:$2.66万
-
财政年份:--
-
负责人:CYNTHIA GUZZO
-
依托单位:
DOSE ESCALATION STUDY OF MEDI 507, HUMANIZED MONOCLONAL ANTIBODY CD2
-
批准号:6303308
-
项目类别:
-
资助金额:$2.51万
-
财政年份:--
-
负责人:CYNTHIA GUZZO
-
依托单位:
DOSE ESCALATION STUDY OF MEDI 507, HUMANIZED MONOCLONAL ANTIBODY CD2
-
批准号:6335128
-
项目类别:
-
资助金额:$18.75万
-
财政年份:--
-
负责人:CYNTHIA GUZZO
-
依托单位:
SAFETY, TOLERABILITY, AND BIOLOGIC ACTIVITY OF L 733,723 IN PSORIATIC PATIENTS
-
批准号:6113259
-
项目类别:
-
资助金额:$2.66万
-
财政年份:--
-
负责人:CYNTHIA GUZZO
-
依托单位:
PHASE I STUDY OF BMS188667 IN PSORIASIS VULGARIS
-
批准号:6113244
-
项目类别:
-
资助金额:$2.66万
-
财政年份:--
-
负责人:CYNTHIA GUZZO
-
依托单位:
BMS 188667 (CTLA4KG) IN PATIENTS WITH PSORIASIS VULGARIS
-
批准号:6113318
-
项目类别:
-
资助金额:$2.66万
-
财政年份:--
-
负责人:CYNTHIA GUZZO
-
依托单位:
PHASE I STUDY OF BMS188667 IN PSORIASIS VULGARIS
-
批准号:5216106
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:CYNTHIA GUZZO
-
依托单位:--
DOSE ESCALATION STUDY OF MEDI 507, HUMANIZED MONOCLONAL ANTIBODY CD2
-
批准号:6327755
-
项目类别:
-
资助金额:$18.75万
-
财政年份:--
-
负责人:CYNTHIA GUZZO
-
依托单位:
海外基金